Share this article on:

Prevalence of Syphilis Seroreactivity in the United States: Data From the National Health and Nutrition Examination Surveys (NHANES) 2001–2004

Gottlieb, Sami L. MD, MSPH*; Pope, Victoria PhD*; Sternberg, Maya R. PhD*; McQuillan, Geraldine M. PhD; Beltrami, John F. MD, MPH&TM*; Berman, Stuart M. MD, ScM*; Markowitz, Lauri E. MD*

Sexually Transmitted Diseases: May 2008 - Volume 35 - Issue 5 - p 507-511
doi: 10.1097/OLQ.0b013e3181644bae
Articles

Background: There have been no recent US population-based estimates of syphilis seroprevalence. We determined the prevalence of syphilis seroreactivity among a representative sample of the US population.

Methods: Sera from 18- to 49-year-old participants in the National Health and Nutrition Examination Surveys 2001–2004 were tested for syphilis IgG antibody using an enzyme immunoassay (EIA). Specimens with positive or indeterminate EIAs underwent rapid plasma reagin (RPR) testing; RPR titers ≥1:8 were considered positive. Specimens with RPR titers <1:8 underwent confirmatory testing with Treponema pallidum particle agglutination (TP-PA).

Results: Sera were available for 5767 participants. EIA testing was positive or indeterminate for 126, of which 10 had RPR titers ≥1:8. Of the remaining 116 specimens, 60 had positive TP-PA tests, including all 19 with RPR titers >1:1. Overall weighted syphilis seroprevalence was 0.71% (95% CI: 0.51–0.96). Prevalence was similar among males (0.76%) and females (0.67%) and increased with age, less education, and lower income (P <0.001 for each). Non-Hispanic blacks had the highest prevalence (4.3%), followed by Mexican-Americans (0.98%) and non-Hispanic whites (0.07%; P <0.001).

Conclusions: The prevalence of syphilis seroreactivity was low (0.71%) in the general US population of 18- to 49-year-olds. However, consistent with surveillance data, this nationally representative survey showed substantial disparities in syphilis by race/ethnicity.

A nationally representative survey (NHANES 2001–2004) showed that syphilis seroprevalence was 0.71% in the general population of US 18- to 49-year-olds with substantial disparities by race/ethnicity.

From the *Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia; and †National Center for Health Statistics, Centers for Disease Control and Prevention, Washington, DC

The authors thank Martha Fears and Susan Kikkert for their laboratory work. We also acknowledge Dr. Anthony Marfin who assisted with the initiation of this study.

Supported by the Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.

Presented, in part, at the 2006 National STD Prevention Conference, Jacksonville, FL, May 8–11, 2006; Abstract P153.

Correspondence: Sami Gottlieb, MD, MSPH, Division of STD Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, MS E-02, Atlanta, GA 30333. E-mail: sgottlieb@cdc.gov.

Received for publication September 5, 2007, and accepted December 4, 2007.

© Copyright 2008 American Sexually Transmitted Diseases Association